MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference, USA Edition

WHAT TO EXPECT

Molecular Diagnostics

Integrated Host-Microbe Plasma Metagenomics for Precision Diagnosis of Sepsis
Liquid Biopsies and Blood Based Molecular Diagnostics
COVID from different perspectives
Utility of Microbial Metagenomics in a Cancer Patient Population
Quality Management in Molecular Diagnostics
NGS based Molecular Diagnostics
Molecular Diagnostics in Infectious Diseases
Molecular Diagnostics in preventive medicine
Future Molecular Diagnostics and New Diagnostic Technologies
Molecular Diagnostics in Laboratory Medicine and Genetics

Infectious Disease Diagnostics

Clinical Metagenomic Sequencing for Diagnosis of Infections
Use of POCT to Improve Outpatient Antibiotic Use
Emerging infectious diseases
Portable point-of-care testing systems and increasing global access to care
Host Response-Based Diagnostics for Infectious Disease
Evaluating non-invasive screening strategies and Point of care testing for liver diseases
The impact of the covid-19 pandemic on diagnostic innovation for infectious disease
Multiplex Blood-Borne Pathogen Detection
Food & Water-Borne Infectious Diseases
Advances in testing and multiplexing

Learn about innovative devices and procedures for effective diagnostics
Meet global heads of infectious disease and molecular diagnostics from the industry and Academics
Participate in discussions with experts on how technology implementation can be improved
Attracting and retaining world-class talent
Resolve common R&D challenges
Discover the latest technology implementations in the industry
Discover best-in-class solutions during the workshop sessions
Interactive panel discussions
120+ Professionals Attending
Case studies presented from leading technology collaborations

Hospitals/Universities/Labs

Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics
Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators
Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians
Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Opening Remarks from the Chairperson TBA, Senior Representative, Co-Diagnostics, Inc,	09:00 - 09:10
IMPLEMENTATION AND INTERPRETATION OF ADVANCED MOLECULAR DIAGNOSTICS
Keynote Presentation - HIV, AIDS, STD are the most transmitted diseases in these days. Vaccine Pharmacovigilance: Lessons Learned from the COVID-19 Pandemic Jamar Shaw, Sr. Infection Control Practitioner , Emory Healthcare	09:10 - 09:40
Molecular Diagnostics in Laboratory Medicine and Genetics Michael Linden, Medical Director, Wake Forest Baptist Health Molecular Diagnostics Laboratory Immunohistochemistry	09:40 - 10:10
Managing Bacterial Antibiotic Resistance on Earth and Space A. C. Matin, Professor of Microbiology & Immunology, Emeritus Stanford University School of Medicine	10:10 - 10:40
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:40 - 11:30
Food and Water Borne Infectious Diseases	11:30 - 12:00
REIMAGING DIAGNOSTICS WITH SMART TECHNOLOGIES
Syndromic testing in clinical microbiology: is it worth the money?	12:00 - 12:30
Use of POCT to Improve Outpatient Antibiotic Use	12:30 - 13:00
Lunch and Poster Presentation \| One-on-One Networking Meetings	13:00 - 14:00
Clinical Metagenomic Sequencing for Diagnosis of Infections	14:00 - 14:30
TAILORING MODEL’S AND ADVANCEMENTS UNDER INFECTIOUS DISEASE DIAGNOSTICS POINT OF CARE TESTING
Evaluating non-invasive screening strategies and Point of care testing for liver diseases	14:30 - 15:00
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:00 - 15:50
PROMISING DIAGNOSTIC TECHNIQUES IN THE ERA OF CONSOLIDATION
Flu Testing - Validation Process and The Revalidation Post Flu Season	15:50 - 16:20
T-Cell Homing in Virus Infection	16:20 - 16:50
Electrochemical Biosensors and Lab-on-Chip Devices for Molecular and Infectious Diseases Diagnosis	16:50 - 17:20
Closing Remarks from the Chairperson TBA, Senior Representative, Co-Diagnostics, Inc,	17:20 - 17:20
Drinks Reception & Networking	17:20 - 17:20
End of Day 1	17:20 - 17:20

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:55 - 09:00
Host Response-Based Diagnostics for Infectious Disease	09:00 - 09:10
FUTURE MOLECULAR DIAGNOSTICS AND NEW DIAGNOSTIC TECHNOLOGIES
Keynote Presentation: Integrated Host-Microbe Plasma Metagenomics for Precision Diagnosis of Sepsis	09:10 - 09:40
Molecular Diagnostics in Infectious Diseases	09:40 - 10:10
Solution Provider Presentation	10:10 - 10:40
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:40 - 11:30
Solution Provider Presentation	11:30 - 12:00
Utility of Microbial Metagenomics in a Cancer Patient Population	12:00 - 12:30
Quality Management in Molecular Diagnostics	12:30 - 13:00
Lunch and Poster Presentation \| One-on-One Networking Meetings	13:00 - 14:00
Molecular Diagnostics in preventive medicine	14:00 - 14:30
SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES
Antimicrobial Susceptibility Testing	14:30 - 15:00
Metagenomics-Based Diagnostics	15:00 - 15:30
Multiplex respiratory virus testing	15:30 - 16:00
Host response vs. pathogen detection	16:00 - 16:30
Rapid infectious disease diagnostics and community surveillance	16:30 - 17:00
Closing Remarks from the Chairperson TBA, Senior Representative, Co-Diagnostics, Inc,	17:00 - 17:20
END OF CONFERENCE	17:20 - 17:20